Correlation Between Lipocine and 025816DA4
Specify exactly 2 symbols:
By analyzing existing cross correlation between Lipocine and AXP 442 03 AUG 33, you can compare the effects of market volatilities on Lipocine and 025816DA4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of 025816DA4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and 025816DA4.
Diversification Opportunities for Lipocine and 025816DA4
Very good diversification
The 3 months correlation between Lipocine and 025816DA4 is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and AXP 442 03 AUG 33 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AXP 442 03 and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with 025816DA4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AXP 442 03 has no effect on the direction of Lipocine i.e., Lipocine and 025816DA4 go up and down completely randomly.
Pair Corralation between Lipocine and 025816DA4
Given the investment horizon of 90 days Lipocine is expected to generate 3.68 times more return on investment than 025816DA4. However, Lipocine is 3.68 times more volatile than AXP 442 03 AUG 33. It trades about 0.06 of its potential returns per unit of risk. AXP 442 03 AUG 33 is currently generating about -0.15 per unit of risk. If you would invest 475.00 in Lipocine on September 14, 2024 and sell it today you would earn a total of 51.00 from holding Lipocine or generate 10.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.41% |
Values | Daily Returns |
Lipocine vs. AXP 442 03 AUG 33
Performance |
Timeline |
Lipocine |
AXP 442 03 |
Lipocine and 025816DA4 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and 025816DA4
The main advantage of trading using opposite Lipocine and 025816DA4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, 025816DA4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 025816DA4 will offset losses from the drop in 025816DA4's long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
025816DA4 vs. Lipocine | 025816DA4 vs. PVH Corp | 025816DA4 vs. Ralph Lauren Corp | 025816DA4 vs. Burlington Stores |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |